BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9891236)

  • 1. Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection.
    Lie AK; Skarsvåg S; Skomedal H; Haugen OA; Holm R
    Int J Gynecol Pathol; 1999 Jan; 18(1):5-11. PubMed ID: 9891236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium.
    Jeffers MD; Richmond J; Farquharson M; McNicol AM
    J Clin Pathol; 1994 Dec; 47(12):1073-6. PubMed ID: 7876377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
    Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
    J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions.
    Soini Y; Pöllänen R; Kemppainen S; Pääkkö P; Lehto VP
    APMIS; 1996 Mar; 104(3):183-90. PubMed ID: 8611192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
    Akasofu M; Oda Y
    Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia.
    Sano T; Masuda N; Oyama T; Nakajima T
    Pathol Int; 2002; 52(5-6):375-83. PubMed ID: 12100520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses.
    Giannoudis A; Herrington CS
    Cancer; 2000 Sep; 89(6):1300-7. PubMed ID: 11002226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix.
    Vecchione A; Cermele C; Giovagnoli MR; Valli C; Alimandi M; Carico E; Esposito DL; Mariani-Costantini R; French D
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):343-8. PubMed ID: 7835772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
    Amortegui AJ; Meyer MP; Elborne VL; Amin RM
    Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
    Kurvinen K; Syrjänen K; Syrjänen S
    J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix.
    Tervahauta A; Syrjänen S; Syrjänen K
    Int J Gynecol Pathol; 1994 Jul; 13(3):234-40. PubMed ID: 7928056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
    Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle regulators p105, p107, Rb2/p130, E2F4, p21CIP1/WAF1, cyclin A in predicting cervical intraepithelial neoplasia, high-risk human papillomavirus infections and their outcome in women screened in three new independent states of the former Soviet Union.
    Santopietro R; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Cintorino M; Tosi P; Syrjänen K; Syrjänen S
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1250-6. PubMed ID: 16835319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia.
    Resnick M; Lester S; Tate JE; Sheets EE; Sparks C; Crum CP
    Hum Pathol; 1996 Mar; 27(3):234-9. PubMed ID: 8600036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 antigen in cervical condylomata, intraepithelial neoplasia, and carcinoma: relationship to HPV infection and integration.
    Cooper K; Herrington CS; Evans MF; Gatter KC; McGee JO
    J Pathol; 1993 Sep; 171(1):27-34. PubMed ID: 8229452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions.
    Zehbe I; Rätsch A; Alunni-Fabbroni M; Burzlaff A; Bakos E; Dürst M; Wilander E; Tommasino M
    Oncogene; 1999 Apr; 18(13):2201-11. PubMed ID: 10327066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions.
    Skyldberg B; Fujioka K; Hellström AC; Sylvén L; Moberger B; Auer G
    Mod Pathol; 2001 Apr; 14(4):279-84. PubMed ID: 11301343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
    Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
    Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
    Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.